Cargando…
Circulating Cancer Associated Macrophage-like Cells as a Potential New Prognostic Marker in Pancreatic Ductal Adenocarcinoma
Background: Circulating Cancer Associated Macrophage-like cells (CAMLs) have been described as novel liquid biopsy analytes and unfavorable prognostic markers in some tumor entities, with scarce data for Pancreatic Ductal Adenocarcinomas (PDAC). Methods: Baseline and follow-up blood was drawn from r...
Autores principales: | Nitschke, Christine, Markmann, Benedikt, Konczalla, Leonie, Kropidlowski, Jolanthe, Pereira-Veiga, Thais, Scognamiglio, Pasquale, Schönrock, Martin, Sinn, Marianne, Tölle, Marie, Izbicki, Jakob, Pantel, Klaus, Uzunoglu, Faik G., Wikman, Harriet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687633/ https://www.ncbi.nlm.nih.gov/pubmed/36428523 http://dx.doi.org/10.3390/biomedicines10112955 |
Ejemplares similares
-
Characterization of RARRES1 Expression on Circulating Tumor Cells as Unfavorable Prognostic Marker in Resected Pancreatic Ductal Adenocarcinoma Patients
por: Nitschke, Christine, et al.
Publicado: (2022) -
Tumor-Stroma Interaction in PDAC as a New Approach for Liquid Biopsy and its Potential Clinical Implications
por: Götze, Julian, et al.
Publicado: (2022) -
Clinical Relevance of Circulating Tumor Cells in Esophageal Cancer Detected by a Combined MACS Enrichment Method
por: Woestemeier, Anna, et al.
Publicado: (2020) -
Clinical Relevance of Loss of 11p15 in Primary and Metastatic Breast Cancer: Association with Loss of PRKCDBP Expression in Brain Metastases
por: Wikman, Harriet, et al.
Publicado: (2012) -
Discovery of Targetable Genetic Alterations in NSCLC Patients with Different Metastatic Patterns Using a MassARRAY-Based Circulating Tumor DNA Assay
por: Belloum, Yassine, et al.
Publicado: (2020)